Welcome To Nutrify Snips

A recent study has shown that fermented soybean (FSB) supplementation may be an effective new treatment for gastroesophageal reflux disease (GERD), which impacts millions globally. Involving 110 participants over 12 weeks, the study required participants to take 1 gram of FSB daily, assessing symptoms with the Reflux Disease Questionnaire (RDQ) and measuring inflammatory markers such… Read More

Recent studies suggest a promising role for probiotics in mental health, specifically through their impact on the gut-brain axis. Research shows that probiotics can modulate brain activity related to emotional regulation and cognitive processing, as revealed by task-based functional MRI studies. These findings extend to patients with major depressive disorder and irritable bowel syndrome (IBS),… Read More

A recent study has shown that Metabolaid, a natural blend of lemon verbena and hibiscus from Monteloeder, may significantly support weight loss efforts. Backed by 10 preclinical and clinical studies, Metabolaid has been linked to increased levels of GLP-1, a hormone crucial for regulating appetite and satiety. In a trial involving 61 overweight adults taking… Read More

The FDA has approved Cobenfy (xanomeline and trospium chloride) for treating schizophrenia in adults, marking a breakthrough as the first antipsychotic to target cholinergic receptors instead of dopamine receptors. Schizophrenia, a chronic mental illness affecting about 1% of Americans, causes psychotic symptoms and cognitive difficulties, and is a leading cause of disability globally. Cobenfy’s efficacy… Read More

A recent study highlights the promise of algae as a sustainable, nutritious protein source comparable to soy. In a randomized, controlled trial, 19 healthy Chinese males consumed noodle meals enriched with either nori or Chlorella vulgaris biomass/protein concentrate, alongside a soy protein control. The algae-enriched meals performed well in palatability, with nori and Chlorella outperforming… Read More